• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

Catalog Number 21341
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Manufacturer Narrative
A customer reported a misidentification of a brevundimonas vesicularis rcpa survey strain as sphingomonas paucimobilis, when testing vitek® 2 gn card lots using vitek® 2 software version 7. 01. The customer did not submit the strain and raw data for evaluation. An investigation was performed. The customer submitted two lab reports for evaluation. Both lab reports showed an excellent identification of s. Paucimobilis. One report had two (2) atypical reactions (dcel+ and ggaa-) and the other had three (3) atypical reactions (dcel+, ggaa-, suct+) for an identification of b. Vesicularis according to the vitek® 2 gn knowledge base. A review of quality records confirmed the gn lots (241398040 and 241393910) met quality control performance testing and final release criteria. The investigation concluded that the strain exhibits atypical growth behavior. The vitek® 2 gn test kit performed as intended.
Event Description
A customer in (b)(6) notified biomérieux of a misidentification associated with vitek® gn test kit (reference 21341) involving an rcpa sample. The customer reported the organism was identified by the vitek® gn card as spingomonas paucimobilis twice and once as a slashline (brevundimonas vesicularis/diminuta) instead of brevundimonas vesicularis as expected. There is no indication or report from the laboratory or physician that the discrepant result led to any adverse event related to a patient's state of health. An internal biomérieux investigation will be initiated.
Manufacturer Narrative
A customer from colombia reported discrepant values for the vidas® prolactin test kit when compared to the chemiluminescence method, for prolactin control samples from a patient that were tested on (b)(6) 2017. The customer did not provide a sample or test report for evaluation. An investigation was performed. A review of quality records confirmed the vidas® prolactin test kit (lot 1005172980) met specifications. The quality product laboratory has tested a calibration sample and six internal samples on a retained vidas® prolactin test kit (lot 1005172980). The results were: (b)(6). The results obtained for the calibration sample and six internal samples were within the specifications. The analysis of the control charts plus one additional sample of high concentration ([123. 5-199. 54] ng/ml 3is) showed that vidas® prolactin test kit (lot 1005172980) was within the trend of the other batches. The vidas® prolactin test kit (lot 1005172980) performed as intended. The customer did not provide a sample or information related to the other method used, thus further investigation is not possible.
Manufacturer Narrative
The previous supplement was incorrectly submitted and is not associated with this device and event.
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of DeviceVITEK 2 GN TEST KIT
Manufacturer (Section D)
595 anglum road
st. louis MO 63042
Manufacturer (Section G)
595 anglum road
st. louis MO 63042
Manufacturer Contact
ellen weltmer
595 anglum road
st. louis, MO 63042
MDR Report Key6509086
MDR Text Key247101259
Report Number1950204-2017-00126
Device Sequence Number1
Product Code JTO
Combination Product (y/n)N
Reporter Country CodeMY
PMA/PMN Number
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation
Type of Report Initial,Followup,Followup,Followup
Report Date 08/16/2017
1 Device was Involved in the Event
0 Patients were Involved in the Event:
Date FDA Received04/20/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator
Device Expiration Date09/26/2017
Device Catalogue Number21341
Device Lot Number241393910
Was Device Available for Evaluation? No Answer Provided
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received07/25/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No Answer Provided
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial